Stockreport

Aligos Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF Net loss: US$87.7m (loss narrowed by 8.7% from FY 2022). US$1.36 loss per share (improved from US$2.25 loss in FY 2022). All figures shown in the chart above are fo [Read more]